In previous studies on inflammatory responses, NLR (28), CRP (29), and ALT (30), as reliable and easily accessible indicators of immune-inflammatory reactions, have been demonstrated to play significant predictive roles in various diseases, including multiple solid tumors such as esophageal cancer, and are commonly used to assess the severity of systemic inflammatory responses. Here, CRP is linked to esophageal cancer.